Angel News


Back to Homepage

21st April 2021

Biotech startup Halo Therapeutics develops COVID treatments

A team of top scientists from the University of Bristol have formed a new biotech company that is developing ground-breaking and newly patented potential treatments for Coronavirus.

Bristol-based Halo Therapeutics is backed by Charles Grimsdale (former Eden Ventures), Keith MacDonald and Mark Farmer (of Eden Ventures) and a group of Angels from the Bristol area.  It was founded by the team of leading scientists who made a recent breakthrough discovery, which was published in Science Magazine. They found that exposing the SARS-CoV-2 (Coronavirus) virus to a free fatty acid called linoleic acid locks the virus’s spike protein into a closed, non-infective form stopping it in its tracks.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage